Tricaprilin In Age-Associated Memory Impairment

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Accera, Inc.; Cerecin

Criteria

Inclusion Criteria:

• Complaints that memory has declined since young adult life

• Scores on standardized tests that are at least one standard deviation below the mean score of young adults

Exclusion Criteria:

• Dementia, including Alzheimer's disease and Mild Cognitive Impairment (MCI)

• Drugs that impair cognition

• Psychiatric conditions that may impair cognition (e.g.,depression etc.)